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INTR O D U CTIO N
A Happy Mother Is Obstetrician’s Pride
A Healthy baby is Nation’s pride
This clearly  picturises the dynamic role of obstetricians in shaping 
a happy house, prosperous nation and healthy third generation. With the 
advent of tremendous advancement of paediatric care, investigations and 
surgical  skills,  a  new horizon has  developed in  improving the  human 
stock  and  decrease  the  perinatal  mortality,  the  lion  share  of  which  is 
congenital malformations2.
Thanks to the development of modern technology of ultrasound, 
MRI,  amniocentesis,  chorionic  villous  sampling  and  Percutaneous 
umbilical blood sampling which have aided in prenatal diagnosis and has 
avoided  unnecessary  surgery,  false  hopes  to  the  mother  and 
embarrassment to the obstetrician who is the first paediatrician.
The rapid development of technology allowing early and accurate 
prenatal  diagnosis  of  fetal  disorder  has  revolutionised  the  practice  of 
obstetrics over 20 years. Beginning with simple cytogenetics17 to detect 
chromosomal abnormality in amniotic fluid cells, there are new methods 
that permit rapid detection of mutant genes by using minute quantities of 
fetal  DNA37.  These  techniques  coupled  with  molecular  genetics  allow 
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detection of a list of inherited conditions that is expanding8 almost daily. 
Of paramount importance is the ability to provide counselling regarding 
various screening, diagnostic technique and treatment options.
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REVIEW OF LITERATURE
Potter defined  congenital  malformation  as  an  “  abnormality  of 
structure detected at birth or during first few weeks of life26  ”. It can be 
expanded  to include functional disturbances in the organs.
Congenital  conditions  can  be  referred  to  as  diseases,  defects, 
disorders, anomalies, or simply genetic differences. The usage overlaps, 
but  also  involves  a  valued  judgement  as  to  the  harmfulness  of  the 
condition.
MALFORMATION  :  The  structure  is  programmed  to  develop 
abnormally.
DEFORMATION  :  Genetically  normal  tissue  destined  to  develop 
abnormally due to forces imposed by uterine environment.
DISRUPTION : More severe change in the form or function that occurs 
in genetically normal tissue when subject to specific insult19.
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EMBROGENESIS
Fertilization occurs in the fallopian tube from few hours to no more 
than a day after ovulation35.
Slow cleavage in 3 days
Morula  formed in tube enters uterus
                         7 days
Embryo hatching and blastocyst implantation
    
ORGANOGENESIS
3rd week        : Neural plate develops from ectoderm
Cardiogenic plate develops from mesoderm
End of  3rd week : Fore and hind gut from endoderm.
Closure of anterior & posterior neural pore is completed on 26th 
and 27th day respectively24.
ETIOLOGY
About 3% of newborns have a "major physical anomaly", meaning 
a physical anomaly that has cosmetic or functional significance.
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Congenital malformations involving the brain are the largest group 
at 10 per 1000 live births, compared to heart at 8 per 1000, kidneys at 4 
per 1000, and limbs at 1 per 1000. All other physical anomalies have a 
combined incidence of 6 per 1000 live births16.
Congenital  malformations  of  the  heart  have  the  highest  risk  of 
death in infancy, accounting for 28% of infant deaths due to birth defects, 
while  chromosomal  abnormalities  and  respiratory  abnormalities  each 
account for 15%, and brain malformations about 12%42.
The  cause  of  40-60%  of  congenital  physical  anomalies  (birth 
defects) in humans is unknown. These are referred to as sporadic birth 
defects, a term that implies an unknown cause, random occurrence, and a 
low recurrence risk for future children25. For 20-25% of anomalies there 
seems to be a "multifactorial" cause, meaning a complex interaction of 
multiple  minor  genetic  abnormalities  with  environmental  risk  factors. 
Another 10-13% of anomalies have a purely environmental cause (e.g. 
infections,  illness,  or  drug  abuse  in  the  mother).  Only  12-25%  of 
anomalies  have  a  purely  genetic  cause.  Of  these,  the  majority  are 
chromosomal abnormalities41.
Genetic  causes of  congenital  anomalies  include  inheritance of 
abnormal genes from the parents, as well as new mutations in one of the 
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germ cells that gave rise to the fetus.
3 basic categories
         1) Numerical defects- Aneuploidy, Polyploidy
         2) Structural defects - Deletions, Inversions, Translocation.
         3) Mosaicism7.
NUMERICAL DEFECTS
Trisomy is the most common and of that Down’s is the common 
cytogenetic abnormality28. 
MATERNAL AGE INCIDENCE
25-30 1 in 1400
30-35 1 in 900
35-40 1 in 350
40-45 1 in 100
>45 1 in 25
Paternal age has no role in the risk factor for Down’s, but there is 
an  increased  risk  of  spontaneous  new  mutations  causing  autosomal 
dominant diseases29.
85% - Due to meiotic  non dysjunction of  chromosome, sporadic 
6
in  occurrence and  associated with rising maternal age.
3-5% - Due to translocation,  familial in occurrence, no association 
with maternal age.
PHENOTYPE: Marked hypotonia,  protruded tongue,  small  head 
with flat occiput, flat nasal bridge, up-slanting palpebral fissures, single 
palmar crease. Associated major anomalies include endocardial cushion 
defects, Gastro intestinal atresia, leukemia and thyroid disease.
RECURRENCE RISK30
FATHER 
KARYOTYPE
MOTHER
KARYOTYPE
RISK
Normal Normal < 1 %
Translocation
13/21, 14/21, 21/22
Normal 2.3 %
Normal
Translocation
11.9%
Translocation  21/21 Translocation  21/21 100%
Other  trisomies  like  18  and  13  result  in  recognisable  life 
threatening  pattern of  malformations. Monosomy conceptuses die prior 
to implantation and universally incompatible with life36.
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STRUCTURAL ABNORMALITIES
DELETION: A portion of  chromosome is  missing and the errors  are 
described by the location of two break points within the chromosome. 
Most  deletions  occur  during  meiosis  and  result  from  misalignments 
during pairing of homologous chromosomes38.
TRANSLOCATION
1. RECIPROCAL  TRANSLOCATION  is  a  rearrangement  of 
chromosomal  material  in  which  breaks  occur  in  two  different 
chromosomes and the fragments  are exchanged before the breaks are 
repaired.  The  rearranged  chromosomes  are  termed  derivative 
chromosomes. If no chromosomal material is gained or lost it is called 
balanced translocation6.
2.  ROBERTSONIAN TRANSLOCATION results when the long arms 
of two individual acrocenteric chromosomes fuse at the centromere to 
form  one.  Fusion  at  the  centromere  results  in  the  loss  of  one 
centromere and satellite regions10 which comprise the short arms.
3. INVERSIONS:  Result  when  two  breaks  occur  in  the  same 
chromosome and the intervening genetic material is inverted before 
the  breaks  are  repaired.  Inversions  cause  problems in  chromosome 
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alignment and hence the carrier  has high risk to produce abnormal 
offspring18.
4. MOSAICISM: It  is  defined as two or more cytogenetically distinct 
cell lines in the same individual. The phenotypic expression depends 
on many factors like whether the abnormal cells involve the placenta, 
fetus, or  some combination23.
SEX CHROMOSOMAL ABNORMALITIES
TURNER’S syndrome - 45(XO) only monosomy compatible with 
life. Prevalence in live born neonates is 1 in 5000. It is associated with 
20% of 1st trimester abortions. Features include short stature, shield chest, 
congenital  lymphedema, webbed neck,  bone abnormalities.  Coarctation 
of aorta, duodenal atresia are major causes of death in this syndrome27.
KLINEFELTER’S syndrome - 47 XXY associated with tall stature, 
enunchoid  proportions,  failure  to  develop  secondary  sexual 
characteristics, cryptorchidism, gynaecomastia  and  mental  retardation22.
SINGLE GENE (MENDELIAN) DISORDERS
Mendelian disorders are caused by a mutation in the single gene or 
locus in one or both the members of a gene pair.
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Types  
 Autosomal dominant.
 Autosomal recessive.
 X-linked diseases.
TERATOGENS
Environmental causes of congenital anomalies are referred to as 
teratogens. These are generally problems with the mother. Teratogens can 
include dietary deficiencies,  toxins, or infections.  For example,  dietary 
deficiency of maternal folic acid is associated with spina bifida. Ingestion 
of  harmful  substances  by  the  mother  (e.g,  alcohol,  mercury,  or 
prescription  drugs  such  as  phenytoin)  can  cause  recognisable 
combinations of   birth  defects15.
The greatest risk of a malformation due to environmental exposure 
to a teratogen is between the third and eighth week of gestation. Before 
this time, any damage to the embryo is likely to result in fatality and the 
baby will  not be born. After eight weeks,  the fetus and its organs are 
more developed and less sensitive to teratogenic incidents.
INFECTIONS
Several infections which a mother can contract during pregnancy 
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can also be teratogenic. These are referred to as the TORCH infections.
      TOXOPLASMOSIS    
         1. Hydrocephalus
         2. Microcephaly
         3. Chorioretinitis    
      RUBELLA4                          
         1. Cataract                               
         2. Cardiac defects                 
         3. Deafness                                 
         4. Glaucoma                               
         5. Microcornea
         6. Mental retardation
        CYTOMEGALOVIRUS5 
                1. Microcephaly
      2. Mental retardation
      3. Chorioretinitis
      4. Sensorineural deafness
      5. Thrombotic thrombocytopenic purpura
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         VARICELLA ZOSTER
                1. Microcephaly
                2. Microphthalmia
                3. Hydranencephaly
                4. Skin vesicles and scars
        
          SYPHILIS
                 1. Vesiculo bullous lesions 
                 2. Saber - shin
                 3. Generalised lymphadenopathy
                 4. Saddle nose.
      
 DIABETES MELLITUS
Pre-gestational  diabetes  is  more  notorious  to  cause  fetal 
embryopathy. The incidence shoots upto 5-6% (2 fold higher than normal 
population). High HbA1c levels directly correlate with the incidence of 
malformations rising to more than 50% if levels are more than 109.
CENTRAL NERVOUS SYSTEM
Anencephaly
Holoproscencephaly
Encephalocele
HEART AND GREAT VESSELS Ventricular septal defect
Atrial septal defect
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Transposition of great vessels
Coarctation of aorta
SKELETAL&SPINAL Caudal regression syndrome
GENITOURINARY
Renal agenesis
Ureteral duplication
GASTROINTESTINAL                     Anal atresia
TERATOGENIC DRUGS
In 1979 Food and drug administration classified drugs  into 5 categories12 
CATEGORY A:  No fetal risk  e.g. multi vitamins.
CATEGORY B : Animal studies revealed no risk but no human studies 
available. e.g.  Penicillin
CATEGORY C : No adequate studies in animals and humans available. 
Adverse effects in animals have been reported but no human data.
CATEGORY D : Evidence of  fetal risk exist, but benefits outweigh the 
risk.
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CATEGORY X : Proven risk.e.g. Thalidomide
PROVEN TERATOGENS11
COMPOUND MAJOR EFFECT
Thalidomide Phacomelia
Diethyl stilbosterol Genital tract abnormalities
Warfarin Nasal hypoplasia, bone stippling
Androgens Masculanisation of female fetus
Folic acid antagonist Craniofacial defects, growth retardation
Anticonvulsants Craniofacial defects, Neural tube defect, 
development delay
Retinoic acid Craniofacial, cardiac, thymic abnormality
Alcohol Craniofacial defects, development delay
MULTIFACTORIAL   OCCURRENCE
For  20-25%  of  anomalies  there  seems  to  be  a  "multifactorial" 
cause,  meaning  a  complex  interaction  of  multiple  minor  genetic 
abnormalities  with  environmental  risk  factors21.  Recurrence  risk  of 
subsequent  affected  child  is  1-5  %.  Common  anomalies  having 
multifactorial inheritance are cardiovascular defects, neural tube defect, 
cleft lip, cleft  palate, congenital diaphragmatic hernia, pyloric stenosis, 
club foot.
IDIOPATHIC ETIOLOGY 
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Hydrocephalus,  renal  anomalies,  abdominal  wall  defects, 
diaphragmatic hernia do not show a definite etiology.
CLASSIFICATION OF MALFORMATIONS
RCOG in 1997 classified malformations into,
 LETHAL   malformations
 SEVERE  -  Possible survival, severe long-term morbidity
 MODERATE - Short and long term morbidity.
LETHAL MALFORMATIONS
CNS Anencephaly 
URINARY TRACT Bilateral renal agenesis 
MUSCULO SKELETAL Lethal osteochondro dysplasia
SKIN Lethal icthyosis congenita
VARIOUS Body  wall limb complex, giant hygroma
SEVERE MALFORMATIONS
CNS
Microcephaly, hydrocepalus, 
holoproscencephaly,  spina  bifida, 
encephalocele
RESPIRATORY Pulmonary hypoplasia, sequestration, Pierre robbin sequence, tracheal stenosis
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CARDIAC Defects requiring intervention within 12 months of life except PDA and ASD
GASTRO INTESTINAL Esophageal atresia, TOF, omphalocele, 
gastroschisis, intestinal atresia, 
hirschprung’s, ectopic anus, EHBA
URINARY     TRACT Unilateral renel agenesis, renal cystic 
disease, severe obstructive uropathy, 
posterior urethral valve.
GENITAL Absent uterus
MUSCULO SKELETAL
Diaphragmatic hernia,arthogryposis 
multiplex, severe deformity of spine, 
absence of limb
SKIN Ectodermal dysplasia of skin
MODERATE MALFORMATIONS
RESPIRATORY Septal deviation, choanal atresia, laryngocele
CARDIAC Defects other than complex anomalies
URINARY Hydronephrosis, ureteral duplication, vesico 
ureteral reflux, urachal anomaly
GENITAL Imperforate hymen, hypospadias, penile 
abnormalities
MUSCULO 
SKELETAL 
Craniostosis, synostosis, hip dysplasia
EYE, EAR, FACE Microtia, aniridia, eyelid defects, cataract, 
facial clefts
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CENTRAL NERVOUS SYSTEM ANOMALIES
NEURAL TUBE DEFCTS
              Neural tube defects occurs in 1.6 per 1000 live births.1.
1. ANENCEPHALY
 The most common nervous system malformation.  
 More frequent  in  females,  thought  to  occur  around  28 days of 
gestation, severe neurologic impairment. 
 Anterior end of the neural tube presents as large skull defect and 
exposed brain, posterior fossa often spared. 
2. ENCEPHALOCELE
Protrusion of brain parenchyma through small defect in skull. It is 
a  common  association  with  many  chromosomal  defects  and  many 
syndromes.
3. SPINA BIFIDA
 Occulta  – Has intact meninges and cord, may have skin dimple, 
hair tuft and usually asymptomatic. 
 Meningocele - Cystic   outpouching of  meninges. 
 Myelomeningocele  -  More  common  than  meningocele,  most 
commonly lumbosacral with cord and meninges in cyst,  may be 
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covered  by  skin  &  present  with  lower  cord  symptoms  (legs, 
bladder, bowel). 
4. ARNOLD CHIARI MALFORMATIONS
TYPE 1 Protrusion  of  cerebellar  tonsils  down  into  foramen  with 
hydrocephalus, hydro - syringomyelia
TYPE II Vermis  extension  through  foramen  magnum,  medullary 
kinking,  midbrain  beaking  associated  hydrocephalus, 
myelomeningocele,  aqueductal  stenosis,  hydro-
syringomyelia 
TYPE III Occipital encephalocele 
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                        MENINGOMYELOCELE
19
‘ Frog eye ’ 
appearance
ANENCEPHALY
PRE NATAL DIAGNOSIS
Prenatal  diagnosis  identifies  the  structural  and  functional 
abnormalities in an unborn fetus.
GOALS OF PRENATAL DIAGNOSIS
 Detection of major abnormalities
 Informative counselling
 Offers selective termination of pregnancy
 Mental preparation
 Intra-uterine fetal therapy
 Optimise delivery
Prenatal diagnosis is recommended in the following cases
 The pregnant woman is 35 years or older at the time of delivery39. 
 She or her parents have had a previous child with a chromosomal 
abnormality. 
 She has a history of recurrent abortions, or her husband's previous 
wife experienced several miscarriages. 
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 A history of parental consanguinity is present. 
 The  pregnant  woman  is  affected  with  type  1  diabetes  mellitus, 
epilepsy, or myotonic dystrophy. 
 She  is  exposed  to  viral  infections,  such  as  rubella  or 
cytomegalovirus. 
 The mother is exposed to excessive medication or to environmental 
hazards. 
 In her or her spouse's family, a history of Down syndrome or some 
other chromosomal abnormality is present. 
 A history of single gene disorder is present in her or her spouse's 
family. 
 Her male relatives have Duchenne muscular dystrophy or severe 
hemophilia. 
 She  is  suspected  of  having  some  other  harmful  gene  on  her  X 
chromosomes. 
 The fetus is diagnosed in utero to have some hereditary error of 
metabolism. 
 The fetus is detected to be at increased risk for a Neural tube defect 
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PRENATAL SCREENING
Prenatal  screening is  achieved by Biochemical,  Sonological  and 
Genetic assessment.
DOWN’S SYNDROME SCREENING
FIRST TRIMESTER 
Combined   test- Placenta Associated Plasma Protein A + Human 
Chorionic Gonadotrophin + Nuchal thickness picks up 85% of cases.
SECOND TRIMESTER
Quadruple  test-↓  Maternal  Serum Alpha Feto Protein + ↑ Beta- 
Human  Chorionic  Gonadotrophin  +↓  Estradiol  +  Inhibin  has    75% 
sensitivity.
AFP is a glycoprotein produced by yolk sac, liver, intestinal tract. 
Concentration is higher in fetus upto 13 weeks, thereafter maternal 
serum shows a steep rise. The MSAFP test has the greatest sensitivity 
between 16-18 weeks gestation, but it also can be performed between 
15-22 weeks gestation. A combination of the MSAFP test and 
ultrasonography detects almost all cases of anencephaly and most cases 
of spina bifida. Also, a NTD can be distinguished from other fetal 
defects, such as abdominal wall defects, by the use of an 
acetylcholinesterase test carried out on amniotic fluid obtained by 
amniocentesis. If the level of acetylcholinesterase rises along with 
Amniotic fluid AFP, it is suspected as a condition of a Neural tube 
defect (Nadel, 1990)
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          INCREASED AFP
Neural  tube  defect,  intestinal 
obstruction,  sacrococcygeal 
teratoma,  abdominal  defects, 
renal  anomalies,  urinary 
obstruction,  skin  defects, 
multifetal  gestation,  low  birth 
weight,  Intra  uterine  fetal 
demise,  underestimated 
gestational  age,  maternal 
hepatoma.
         DECREASED AFP
Trisomies,  gestational  trophoblastic 
disease,  Intra  uterine  fetal  demise, 
high maternal weight, over estimated 
gestational age.
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ULTRASOUND 
Ultrasound hints STRUCTURAL ABNORMALITY and picks up 
40%  of  structural  malformations,  directs  towards  chromosomal 
abnormalities, aids other prenatal diagnostic procedures and points other 
co existent major anomaly. Targeted scan is between 18 to 22 weeks32.
Methodological  approach  includes  viewing  head,  spine,  chest 
abdomen and limbs. Three views in imaging head:
TRANSTHALAMIC 
 Biparietal diameter (BPD)
 Occipitofrontal diameter  (OFD)
 Head circumference (HC)
TRANSVENTRICULAR 
Atria of lateral ventricle, echogenic choroid plexus
TRANSCEREBELLAR 
Posterior fossa structures, transcerebellar diameter (15-22 wks)
24
 
SALIENT FEATURES OF SPECIFIC ANOMALIES
   ANENCEPHALY                                                                                                             
      1. Absence of vault                                   
      2. Short neck                                        
      3. Frog face
     4. Hydramnios        
   ENCEPHALOCELE                                                                       
      1. Paracranial mass                          
      2. Skull defect                                 
   SPINA BIFIDA                                        
      1. Discontinued posterior line                         
      2. Exaggerated spinal curvature                       
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      3. Defect in subcutaneous tissue
      4. Bulging sac
   DIAPHRAGMATIC HERNIA                    
      1. Absent stomach bubble                               
      2. Echogenic bowel loops in thorax        
      3. Dextrocardia                                       
     4. Pulmonary hypoplasia.               
   DUODENAL ATRESIA
        1. Double bubble sign
        2. Polyhydramnios
   RENAL AGENESIS
        1. Absent kidney
        2. Hyperechogenic cyst
        3. Oligohydramnios
                                        OMPHALOCELE
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 FETAL ECHOCARDIOGRAPHY
Fetal  echocardiography can  be performed at  15 weeks  gestation 
and beyond.  When this  technique  is  used  with  duplex or  colour  flow 
Doppler, it can identify a number of major structural cardiac defects and 
rhythm disturbances (Copel, 1987). 
MRI can be a better option when severe oligohydramnios obscures 
the imaging.
INVASIVE PROCEDURES
Amniocentesis is an invasive, well-established, safe, reliable, and 
accurate  procedure  performed  between  14-20  weeks  of  pregnancy. 
Amniocentesis is advised for pregnant women at 35 years or older for 
detection  of  chromosomal  abnormalities  in  the fetus13.  It  is  performed 
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under  ultrasound  guidance.  A  22-gauge  needle  is  passed  through  the 
mother's lower abdomen into the amniotic cavity inside the uterus, and 
10-20 mL of amniotic fluid that contains cells from amnion, fetal skin, 
fetal  lungs,  and urinary tract  epithelium are  collected.  These cells  are 
grown in culture for chromosomal, biochemical, and molecular biologic 
analyses.  Supernatant  amniotic  fluid  is  used  for  the  measurement  of 
substances,  such  as  Amniotic  fluid  alpha  feto  protein,  hormones,  and 
enzymes14. 
The results of cytogenetic and biochemical studies on amniotic cell 
cultures are more than 90% accurate. In the third trimester of pregnancy, 
the  amniotic  fluid  can  be  analysed  for  determination  of  fetal  lung 
maturity. Risks with amniocentesis are rare but include 0.5-1.0% fetal 
loss and maternal Rhesus sensitisation40.
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CHORIONIC VILLOUS BIOPSY
Chorionic  villous  sampling is  performed very  early  in  gestation 
between 9-12 weeks, ideally at 10 weeks gestation. A catheter is passed 
through the cervix or through the abdominal wall into the uterus under 
ultrasound guidance, and a sample of chorionic villi surrounding the sac 
is  obtained.  The  villi  are  dissected  from  the  decidual  tissue,  and 
chromosome  analysis  is  carried  out  on  these  cells  to  determine  the 
karyotype of the fetus3.
DNA  can  be  extracted  from these  cells  for  molecular  analysis. 
DNA analysis  of  Chorionic  villous  sampling  specimens is  helpful  for 
early  diagnosis  of  hemoglobinopathies  (Galjaard,  1987).  In  addition, 
tissue culture can be initiated on these cells for further studies. 
The  major  advantage  of  Chorionic  villous  sampling  over 
amniocentesis  is  getting  quick  results  and  its  use  in  early  pregnancy. 
Abnormalities can be identified at an early stage, and more acceptable 
decisions about termination of the pregnancy can be taken. Abortion is 
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also much safer at this early stage. A disadvantage of Chorionic villous 
sampling  as  compared  to  amniocentesis  is  2-3%  risk  of  causing 
miscarriage, and rarely, Chorionic villous sampling can result with limb 
defects in the fetus (Burton, 1992). Maternal sensitisation is possible. A 
higher  rate  of  maternal  cell  contamination  and  confined  placental 
mosaicism  with  Chorionic  villous  sampling  may  result  in  diagnostic 
ambiguity,  leading to  the  need for  additional  invasive  diagnostic  tests 
(Wang, 1993). 
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PERCUTANEOUS UMBILICAL BLOOD SAMPLING 
Percutaneous umbilical blood sampling or cordocentesis (Daffos, 
1985) is  a method for fetal  blood sampling and is performed after  16 
weeks  gestation.  A  needle  is  inserted  into  the  umbilical  cord  under 
ultrasound guidance, and fetal blood is collected from the umbilical vein 
for  chromosome analysis.  This  technique  is  also  useful  for  evaluating 
fetal  metabolism  and  hematologic  abnormalities.  Complications  are 
bleeding, hematoma, fetal bradycardia and 2.7 % of fetal loss33.
PERCUTANEOUS SKIN BIOPSY
To prenatally diagnose a number of serious skin disorders, such as 
anhidrotic  ectodermal  dysplasia,  epidermolysis  bullosa  lethalis, 
epidermolysis  bullosa  dystrophica,  hypohidrotic  ectodermal  dysplasia, 
oculocutaneous albinism, and genetic forms of ichthyosis, percutaneous 
fetal  skin biopsies  are  taken under  ultrasonic  guidance  between 17-20 
weeks gestation20.
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PREIMPLANTATION BIOPSY OF BLASTOCYSTS OBTAINED 
BY IN VITRO FERTILIZATION
Techniques are being developed to test cells obtained from biopsy 
of early cleavage stage or blastocyst of pregnancies conceived through in 
vitro fertilization (Handyside, 1992). These techniques will be helpful for 
selective transfer and implantation of those pregnancies into the uterus 
that are not affected by a specific genetic disorder31. This approach will 
be more acceptable to those couples who oppose abortions. 
MOLECULAR GENETICS IN DIAGNOSIS34
1. Polymerase chain reaction 
2. Southern blotting
     3. Multiplex polymerase chain reaction 
4.  Fluorescence in situ hybridisation
5. Linkage analysis
POLYMERASE CHAIN REACTION
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  Detects  numerical abnormalities and point mutations, small 
insertion or deletions. It includes amplification  followed  by  restriction
enzyme analysis and direct sequencing.
SOUTHERN BLOTTING
 Detects large structural rearrangements
 Analysis of DNA from complex genomes
 Detects abnormal DNA sequence
 Example Fragile X syndrome 
MULTIPLEX POLYMERASE CHAIN REACTION
           This technique is developed for rapid detection of  sex and 
autosomal aneuploides and the greatest advantage is that the results are 
available within 24 hrs.
FLUOROSCENT IN SITU HYBRIDISATION
FISH is a method of rapid prenatal diagnosis which helps in the 
detection and localisation of specific DNA sequence                             
    
TYPES   -Interphase FISH
                        
       -Metaphase FISH
INTERPHASE FISH
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 It gives faster  results within 24 hours
 Requires fewer cells
 100% success rate
                                  
 Fails to detect mosaicism or deletions
 Identifies only 80% of abnormalities
 Only  aneuploides of chromosome 21,18,13,X,Y  identified
LINKAGE ANALYSIS
 Linkage analysis is done for diseases where specific genes are not
 identified. Polymorphic markers linked to the gene are identified.
 It can trace mutations from parents.
                    AIM OF THE STUDY
1. To  study  the  prevalence   of  congenital   malformations  in  our 
institute.
2. To study the pattern of malformations.
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3. To  assess  the  influence  of  various  risk  factors  such  as  Age, 
Gravidity, Previous Obstetric history, Consanguinity, 1st trimester 
events on the occurrence of malformations.
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MATERIALS & METHODS
The  present  study  was  conducted  at  the  INSTITUTE  OF 
OBSTETRICS  AND  GYNAECOLOGY,  a  tertiary  level  Government 
institution at CHENNAI, Tamil Nadu.
The study was conducted for a period of one year from July 2006 
to July 2007 taking into account all the deliveries that occurred in our 
institution.
The total number of deliveries for the period was 17890.
All the cases booked and unbooked were taken into consideration. 
Some cases have been diagnosed incidentally  in  our  institution.  Some 
have  been  referred  here  with  an  ultrasound  report  for  either 
reconfirmation or for termination.
All  the  cases  detected  to  have  congenital  malformations  by  an 
antenatal ultrasound were analysed by detailed questionnaires. A detailed 
history  regarding  the  patient  and  husband’s  age,  parity,  occupation, 
previous obstetric outcomes, family history of malformed babies, degree 
of consanguinity and the events in the present pregnancy were analysed. 
Any history of maternal exposure to fever, teratogens, drugs and other 
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environmental factors were ascertained. Enquiries were put forward with 
regard to maternal medical diseases like diabetes mellitus. Patients were 
enquired regarding the intake of preconceptional folate.
Investigations pertaining to the case were done if necessary. Blood 
sugar was done in indicated cases.
Mediscan systems extended a big hand in helping out in further 
confirmation of diagnosis and necessary intervention thereafter. Some of 
the specimens of malformed fetuses were sent to them for autopsy after 
getting consent from the patient with their fullest co-operation. Genetic 
counselling was extended to the patients  by the genetic  department  at 
mediscan systems. Prenatal diagnosis were done to find the karyotype of 
the fetus when  genetic etiology was suspected.
Post  delivery,  the  fetus  was  examined  in  detail  with  regard  to 
obvious external anomalies, weight, sex. A live born baby with anomalies 
was  admitted  to  the  newborn  intensive  care  unit  of  our  hospital  and 
followed up thereafter. Surgically correctable anomalies were referred to 
the department of paediatric surgery at Institute of child health.
Mother was given genetic counselling before discharge from the 
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hospital.  She  was  instructed  regarding  future  pregnancy  and  stressed 
upon the importance of pre-conceptional folate intake.
Defects which caused serious structural,  cosmetic and functional 
disability requiring surgical or medical  management were classified as 
major  anomalies.  The  rest  were  categorised  as  minor  anomalies.  The 
major malformations were divided into Central nervous system, Skeletal, 
Gastro-intestinal, Genitourinary, Cardio vascular system syndromes and 
miscellaneous disorders. The babies were followed up in the well baby 
clinics and Institute of Child Health.
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DATA   ANALYSIS
TABLE - I
DISTRIBUTION OF CASES WITH AGE
AGE NO.   OF   CASES PERCENTAGE
< 20 54 21%
21-25 123 49%
26-30 62 24%
31-35 10 4%
>36 5 2%
TOTAL 254
The bulk of our deliveries are confined to the age group of 21-25 
yrs. Though 50 % of malformations occurred in this age group, there is 
no actual correlation between age and defects.
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TABLE - II
 
DISTRIBUTION OF CASES WITH PARITY
PARITY NO. OF CASES PERCENTAGE
Primi gravida 124 48.8%
         Gravida II 79 31.1%
Gravida III 33 12.9%
Gravida  IV 14 5.5%
Gravida  V 4 1.7%
TOTAL 254
There is no significant relationship between parity and congenital 
malformations.
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TABLE – III
DISTRIBUTION OF CASES WITH CONSANGUINITY
DEGREE NO.OF CASES PERCENTAGE
NON 
CONSANGUINEOUS
191 75.3%
III DEGREE   
CONSANGUINEOUS 
45 17.7%
II DEGREE
CONSANGUINEOUS
18 7%
I DEGREE
CONSANGUINEOUS
_
TOTAL 254
In  our  study  the  malformations  occurred  mostly  in  non-
consanguineous marriages. No correlation could be made out between the 
two. 
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24 % of the parents were married consanguineously who gave birth 
to malformed fetuses.
TABLE   - IV
DISTRIBUTION OF CASES WITH SEX
SEX NO. OF  CASES PERCENTAGE
MALE 134 52.7%
FEMALE 111 43.7%
AMBIGUOUS
GENITALIA
9 3.5%
TOTAL 254
The malformations showed slight predilection towards male sex.
INCIDENCE OF PREVIOUS PREGNANCY WASTAGE
                                     56       →    (22%)
INCIDENCE OF PREVIOUS MALFORMATIONS
                                    28       →     (11%)
Around  22  % of  malformed  babies  were  born  to  mothers  with 
previous history of pregnancy wastage and 11 % had previous malformed 
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babies.  This  shows  there  is  a  genetic  role  playing  important  in  the 
etiology of malformations.
TABLE - V
OUTCOME IN MALFORMED FETUSES
OUTCOME CASES TOTAL
LIVE BIRTHS 101 17175
MEDICAL 
TERMINATION OF 
PREGNANCY
102 1410
INTRA UTERINE 
DEATH
51 656
 
The outcome of  malformations are  dependent  on the gestational 
age  at   detection.  Earlier  they  are  picked  up,  more  the  number  of 
recommended  termination .  7.3  % of the terminations were done for 
malformations.
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TABLE - VI
   
CORRELATION BETWEEN MEDICAL ILLNESS & 
MALFORMATIONS
FEVER 13
GESTATIONAL DIABETES 8
EPILEPSY 2
TORCH 3
DRUGS 2
Maternal  febrile  illness  in  the  first  trimester  had  a  definite 
predeliction for malformations as pointed out in previous studies.
Infant of diabetic mothers on evaluation showed a higher rate of 
cardiac and neural defects. 
One  baby  had  fetal  Hydantoin  syndrome,  the  mother  had  been 
taking phenytoin through out her pregnancy.    
TORCH screening is not routinely done for all patients, but three of the 
mothers with recurrent pregnancy wastage showed increased titre.
TABLE - VI
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INCIDENCE OF VARIOUS MALFORMATIONS
SYSTEM INCIDENCE
CENTRAL NERVOUS SYSTEM 131 (51%)
SYNDROMES 44
CARDIOVASCULAR SYSTEM 19
SKELETAL 17
FACE 16
GENITO URINARY TRACT 9
DIAPHRAGMATIC HERNIA 8
GASTRO INTESTINAL TRACT 7
SACROCOCCYGEAL TERATOMA 3
The most common malformations encountered in our hospital were 
Central nervous system defects. The reason sought is they are picked up 
more by antenatal Ultrasound and most of them are lethal anomalies.
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TABLE - VII
INCIDENCE OF VARIOUS CNS MALFORMATIONS
Anencephaly 49
Spinal defects 36
Hydrocephalus 25
Arnold chiari 9
Microcephaly 6
Corpus callosum 3
Holoproscencephaly 3
Anencephaly  was  the  most  reported  defect  followed  closely  by 
spinal  defects.  Peri  conceptional folate were not taken by the patients. 
Only post conceptional folate were taken by few of them.
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TABLE - VIII
INCIDENCE OF VARIOUS CARDIAC DEFECTS
Complex cardiac disease 3
Single ventricle 3
Hypoplastic left ventricle 3
Dextrocardia 3
Transposition of great arteries 2
Septal defects 2
Malformed aorta 1
Truncus arteriosus 1
Ebstein anomaly 1
Only major lethal cardiac defects were detected antenatally and at 
birth which accounted for 7.5 % of malformations.
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TABLE - IX
INCIDENCE OF VARIOUS GASTRO INTESTINAL ANOMALIES
Duodenal  atresia 1
Tracheo esophageal fistula 1
Omphalocele 3
Gastroschisis 1
Imperforate anus 1
TABLE – X
INCIDENCE OF VARIOUS GUT ANOMALIES
Posterior  urethral valve 3
Renal  agenesis 2
Polycystic kidney disease 2
Multicystic  dysplastic kidney 2
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TABLE – XI
INCIDENCE OF VARIOUS SKELETAL ANOMALIES
Polydactyly, syndactyly 9
Short  limbs 3
Congenital talipes equino varus 3
Skeletal  dysplasia 1
Achondroplasia 1
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TABLE – XII
MALFORMATIONS DETECTED BY ULTRASOUND
Detected 190 74.8 %
Not  detected 37 14.5%
Ultrasound  not done 27 10.7%
Ultrasound could pick up only 75 % of the anomalies. 15 % of the 
anomalies were missed by routine Ultrasound which were mostly cardio 
vascular  anomalies.
TABLE – XIII
GESTATIONAL AGE AT WHICH MALFORMATIONS WERE 
DETECTED
Ist trimester 17
IInd trimester 102
IIIrd trimester 71
Most of the anomalies were detected by anomaly scan done in the 
second trimester.
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DISCUSSION
The global incidence of congenital malformations detected at birth 
is 2-3%. In India, the nation wide prevalence is high. However there is no 
systematic surveillance  for birth defects in India.
In studies from other parts of India, the incidence varied from 0.3% 
to 3.6%. The rate in the present study is comparable to the studies from 
Varanasi, Manipal and Allahabad.
A higher incidence of congenital malformations has been reported 
from centers like PGIMER Chandigarh and  JIPMER Pondicherry, which 
may be because of higher autopsy rates at these centers.
THE INCIDENCE FROM OTHER COUNTRIES
         5.5%  Afghanistan
         3.4%  Michigan 
         0.9%  Northampton-shire
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ACCORDING TO BIRTH DEFECTS REGISTRY OF INDIA  2006
1. The overall crude birth prevalence is 92.2 per 10000
2. The crude birth prevalence of birth defects was highest in Mumbai, 
145 per 10000, followed by Hyderabad, Chennai, least were from 
West Godavari.
3. Nervous system defects among which neural tube defects were the 
most prevalent among most system defects across the regions.
4. The  prevalence  of  major  anomalies  overall,  were  25.9  \  10000 
neural tube defects followed by 7.5 \ 10000 of congenital talipes 
equino varus, least 1.7 \ 10000 of renal cystic anomalies. 
RESULTS OF THE PRESENT STUDY
1. The   prevalence of malformations is 147 per 10000.
2. Central  nervous  system  defects  were  the  most  recognised 
malformations at birth and formed the bulk of defects accounting 
of 76\10000. Nervous system malformations are better detected in 
the  antenatal  ultrasound  than  other  systems  and  most  of  the 
anomalies are potentially lethal,  hence accounting for the higher 
numbers.  Moreover  they  are  quite  obvious  to  the  labour  room 
personnel,  requiring no additional confirmation by investigations 
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and imaging.
3. As against the wide prevalence of cardiovascular defects across the 
total  population,  the  reported  prevalence  in  the  present  study  is 
extremely less. This joins hands with rest of the studies done in 
many centres across the country. The reason being;
a) The pick up rate of  cardio vascular defects by ultrasound is 
very low requiring expertise and high resolution machinery.
b) Most of the anomalies are not detected at birth, as they show up 
symptoms later in the first week of life and more. Only lethal 
anomalies  like  complex  cardiac  disease  manifest  in  the 
labouring room.
c) Cardiac defects need to be reconfirmed by imaging like Echo 
and Doppler which are reported later.
d) Around 94 cases of congenital heart disease were suspected and 
picked  up  by  postnatal  follow  up  of  the  baby.  (stastistics 
collected from Institute of child health).
e) From this it is inferred that still cardiac defects form the core of 
congenital defects, for which we need to expertise upon their 
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detection rate and its prevention.
4. Targeted or anomaly scan has halved the burden of birth defects 
and help  the mother to prepare herself for the termination and plan 
the future pregnancies. 75 % of the anomalies were picked up in 
our study by ultrasound. There were of course 15 % missed cases 
by  routine  ultrasound.  10%  of  the  mothers  had  no  scan  done 
through out the pregnancy. Some anomalies were picked up later in 
the third trimester  scans,  which were un-noticed in the previous 
scans.
LIMITATIONS OF THE DATA
1. Data not population based.
2. Passive data collection.
3. Most  of  the  minor  unimportant  anomalies  might  not  have  been 
noticed.
CONCLUSION
Congenital malformations though cannot be prevented totally, can 
be minimised and if detected earlier will reduce the mental agony in the 
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mother and her family. It can be minimised by prenatal counselling, peri 
conceptional folate and prenatal diagnosis
It  has  become  our  professional  responsibility  to  identify  those 
couples who are at risk of having abnormal fetus. 
Early ante-natal diagnosis results in earlier termination which will 
decrease the maternal morbitity  and the mental health in the mother.
Conditions amenable to surgical correction in the neonatal period 
or in utero treatment can be planned if possible.
Broader  the  diagnosis  of  birth  defects  made  if  Obstetricians, 
Perinatalogist, Sonologist and Laboratory Personnel work hand in hand.
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PROFORMA
1. Name                      :
2. Age                      :
3. IP No.                       :
4. Occupation             :
5. Education          :
6. Socioeconomic status :
7. Father’s age  :     
8. Address        :
9. Obstetric code         :
10. Periconceptional folic 
acid intake :
11. Marital history          : Consanguinity / degree
12. Family history  : Congenital problems in the siblings, 
parents .
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13. Obstetric history        :
a. Gravida
b. Parity
c. Abortions
d. Still births
14. Maternal Problems during pregnancy :
a. Fever
b. Drugs
c. TORCH infections
d. Radiation exposure
e. Diabetes 
f. Hypertension 
g. Others
15. Ultrasound done : Yes / No
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16. Gestational age as per ultrasound :
17. USG findings :
18. Date of delivery :
19. Mode of delivery :
20. Status of fetus      : live / still born 
21. If abortion            : Spontaneous / medical termination
22. Sex                       :
23. Birth weight         :
24. Clinical features   :
25. Postnatal followup :
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ABBREVIATIONS
ASD                    - Atrial septal defect
CM                       - Consanguineous marriage
CNS                      - Central nervous system
CTEV                   - Congenital talipes equino varus
DNA                    -Deoxy ribonucleic acid
EHBA                   -Extra hepatic biliary atresia
GA                       - Gestational age
GDM                    - Gestational diabetes mellitus
IUD                      - Intra uterine demise
LN                       - Labour natural
LSCS                   - Lower segment caesarean section 
MRI                     - Magnetic resonance imaging
MSAFP                 - Maternal serum alpha feto protein
MTP                    - Medical termination of pregnancy
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NCM                    - Non consanguineous marriage
NTD                      - Neural tube defect
PDA                    -Patent ductus arteriosus
PUV                      - Posterior urethral valve
RCOG                 -Royal College Of Obstetrics And  Gynaecology
TGA                    - Transposition of great arteries
TOF                      - Tetrology of Fallot
TORCH                - Toxoplasmosis, Rubella, Cytomegalovirus, Herpes
USG                    - Ultrasonography
VBAC                 - Vaginal birth after caesarean
YES/ D                - Detected
YES/ ND             - Not detected
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